OEM/ODM Manufacturer Glioblastoma Multiforme - Vonoprazan Fumarate (TAK-438) CAS 1260141-27-2 881681-01-2 API High Quality – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

With responsible good quality method, good status and excellent client services, the series of solutions produced by our company are exported to lots of countries and regions for Molecular Formula C8H14O5, (R)-(-)-α-Methoxyphenylacetic Acid, LCZ696 CAS 936623-90-4, Please don't hesitate to contact us if you are interested in our products. We firmly believe our products will make you satisfied.
OEM/ODM Manufacturer Glioblastoma Multiforme - Vonoprazan Fumarate (TAK-438) CAS 1260141-27-2 881681-01-2 API High Quality – Ruifu Detail:

Supply Vonoprazan Fumarate and Related Intermediate
5-(2-Fluorophenyl)pyrrole-3-Carboxaldehyde CAS 881674-56-2
Pyridine-3-Sulfonyl Chloride CAS 16133-25-8
Vonoprazan Fumarate (TAK-438) CAS 1260141-27-2 881681-01-2

Chemical Name Vonoprazan Fumarate
Synonyms TAK-438
CAS Number 1260141-27-2; 881681-01-2
CAT Number RF-API99
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C21H20FN3O6S
Molecular Weight 461.463
Brand Ruifu Chemical
Item Specifications
Appearance White or Almost-White Crystalline Powder
Identification 1 H-NMR Consistent with the Standard
Identification IR The IR Absorption spectrum of the sample concordant with reference standard
Identification HPLC The retention time of the sample concordant with reference standard
Related Substances
Impurity A ≤0.20%
Impurity B ≤0.15%
Impurity C ≤0.15%
Any Other Impurity ≤0.10%
Total Impurities ≤1.0%
Residual Solvents
Methanol ≤0.30%
Ethanol ≤0.50%
Ethyl Acetate ≤0.50%
Assay / Analysis Method 98.0%~102.0% (By HPLC)
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture.

1

Vonoprazan Fumurate (TAK-438) (CAS: 1260141-27-2; 881681-01-2), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate (Takecab), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014. Vonoprazan Fumarate is mainly used for the treatment of helicobacter pylori infection, gastroesophageal reflux, peptic ulcer, duodenal ulcer, esophagitis, gastric ulcer and other gastric acid related diseases. The product has a strong, lasting inhibition of gastric acid secretion. At the treatment dose, Vonoprazan Fumarate has little effect on other enzymes and little effect on physiological functions of the body. It is safe and more tolerable.


Product detail pictures:

OEM/ODM Manufacturer Glioblastoma Multiforme -  Vonoprazan Fumarate (TAK-438) CAS 1260141-27-2 881681-01-2 API High Quality – Ruifu detail pictures


Related Product Guide:

Our workforce through professional training. Skilled professional knowledge, solid sense of service, to fulfill the services demands of consumers for OEM/ODM Manufacturer Glioblastoma Multiforme - Vonoprazan Fumarate (TAK-438) CAS 1260141-27-2 881681-01-2 API High Quality – Ruifu , The product will supply to all over the world, such as: Gabon, Bolivia, Liverpool, We always insist on the principle of "Quality and service are the life of the product". Till now, our products have been exported to more than 20 countries under our strict quality control and high level service.
  • Speaking of this cooperation with the Chinese manufacturer, I just want to say"well dodne", we are very satisfied.
    5 Stars By Carey from Sevilla - 2017.11.29 11:09
    The company account manager has a wealth of industry knowledge and experience, he could provide appropriate program according our needs and speak English fluently.
    5 Stars By Fay from The Swiss - 2017.12.02 14:11
    Write your message here and send it to us